Startseite Medizin Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
Artikel Open Access

Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma

  • Jingying Zheng , Lijing Zhao , Yi Wang , Shuhua Zhao EMAIL logo und Manhua Cui EMAIL logo
Veröffentlicht/Copyright: 16. März 2017
Artikel downloaden (PDF)
Open Medicine
Aus der Zeitschrift Open Medicine Band 12 Heft 1

Abstract

The objective of this study was to explore the expression of EpCAM and EGFR in human epithelial ovarian cancer (EOC) and their correlation with clinicopathological parameters.

The protein expression levels of epithelial cell adhesion molecule (EpCAM) and epidermal growth factor receptor (EGFR) were evaluated by immunohistochemistry in formalin-fixed paraffin-embedded specimens from 30 patients with epithelial ovarian carcinoma and 15 normal ovary tissues. Clinicopathological characteristics were gathered by retrospective review of the patients’ files. The correlation between EpCAM and EGFR expression, as well as their association with clinical pathological parameters were investigated. The SPSS 17.0 package was used to perform statistical analyses.

The positive expression rates of EpCAM and EGFR were significantly elevated in epithelial ovarian cancer tissues than in normal ovary tissues. The positive expressions of EpCAM and EGFR in EOC were associated with International Federation of Gynecology and Obstetrics (FIGO) stage and tumor differentiation, lymph node metastasis. Spearman correlation analysis demonstrated a significant positive association between EpCAM and EGFR expression in EOC.

The co-expression of EpCAM and EGFR may play an important role in the carcinogenesis of EOC and might provide a promising molecular therapeutic target.

Keywords: Epithelial ovarian cancer; EpCAM; EGFR; Immunohistochemistry

1 Introduction

Epithelial ovarian cancer (EOC) is the leading cause of mortality from gynecological malignancies and account for 85%~90% of ovarian cancer. Based on GLOBOCAN estimates, there were an estimated 238,700 new ovarian cancer cases and 151,900 deaths worldwide in 2012 [1]. The relatively asymptomatic early stages and the absence of accurate screening methods and biomarkers result in the majority ovarian cancers being diagnosed at advanced stages when metastasis has occurred, followed by migration, implantation and invasion throughout the peritoneal cavity. Despite the use of cytoreduction surgery and subsequent platinum-paclitaxel combination chemotherapy during advanced stages, 25% of patients show resistance to chemotherapy, and the majority ultimately relapse without response to treatment. Accordingly, ovarian cancer has a high mortality rate, with a five year survival near 45% [2]. Given the complex biological behavior of ovarian cancer, the identification of a novel potential therapeutic target is the present clinical challenge.

The epithelial cell adhesion molecule (EpCAM, also called CD326) is a 39~42kDa calcium-independent transmembrane glycoprotein initially discovered as an antigen on human colon carcinoma, and functions as a homophilic, epithelial-specific intercellular adhesion molecule [3]. EpCAM protein is consisted of an extracellular domain with epidermal growth factor-like domain and presumed thyroglobulin domain, a single transmembrane region, and a small 26-amino acid intracellular domain [4]. EpCAM expression is found in epithelium of healthy individuals, except epidermal keratinocytes, gastric parietal cells, hepatocytes, and squamous epithelium. It has been demonstrated that EpCAM is also expressed in the majority of human epithelial-derived carcinomas at levels greater than in human normal epithelium [5]. The role of EpCAM is not only limited to mediating epithelial-specific intercellular adhesion, but it is also involved in cellular signaling, cell proliferation, migration, invasion and differentiation, suggesting it plays an important role in cancer progression and metastasis [6].

Epidermal growth factor receptor (EGFR) is a member of the human epidermal receptor (HER) family, comprisingfour type I transmembrane tyrosine kinase receptors: EGFR (HER1, erbB-1), erbB-2 (HER2 or Neu), HER3 and HER4. EGFR is the expression product of oncogene c-erbB1 and is structurally subdivided into an extracellular ligand-binding domain, a single lipophilic transmembrane domain, and an intracellular tyrosine kinase domain [7]. Upon binding of the ligand to the extracellular domain, EGFR is activated and undergoes homodimerization or heterodimerization, which in turn induces the activation of intrinsic tyrosine kinase and ultimately triggers multiple signaling pathways [8]. The signaling pathways activated by EGFR dimerization play a key role in variety cancer cell behaviors, including regulation of cell proliferation, adhesion, migration, invasion, angiogenesis and resistance to apoptosis [9]. It has been well-documented that overexpression of EGFR is detected in epithelial ovarian cancer and is associated with poor prognosis and chemoresistance [10].

As it is known that overexpression of EpCAM and EGFR are associated with the development and progression of human carcinomasthe present study was conducted to investigate whether there is a correlation between EpCAM and EGFR in EOC progression. Our study utilized immunohistochemistry to detect the expression of EpCAM and EGFR in EOC tissues, and identified the relationship between protein expression and clinical pathological parameters. Further objective were to elucidate the potential associations with EpCAM and EGFR, and determine if EpCAM and EGFR could be a joint molecular therapeutic target in epithelial ovarian cancer.

2 Methods

2.1 Tissue specimens

In this study, 30 Formalin-fixed paraffin-embedded (FFPE) specimens from epithelial ovarian cancer (EOC) patients and 15 FFPE normal ovarian epithelial tissue specimens obtained from normal ovaries during surgery for other gynecological diseases were collected between April 2013 and December 2015 in the Department of Pathology of the Second Hospital of Jilin University. All hematoxylin-eosin slides were reviewed by two pathologists to establish a histological gradiant and type using World Health Organization (WHO) criteria to achieve a consensus diagnosis. None of the EOC patients included in this study had received chemotherapy or radiotherapy before surgical operation. This study was approved by the Medical Ethics Committee of the Second Hospital of Jilin University and written informed consent was obtained from each participant.

2.2 Immunohistochemical Staining

4-micrometre sections were cut from FFPE tissue specimens. The sections were mounted and baked at 60°C for 1 hour. Then the sections were deparaffinized in xylene and rehydrated in a series of graded alcohol. Endogenous peroxidase activity was removed by incubation the sections with 3% H2O2 for 5 minutes. The sections were heated in an autoclave in retrieval buffer (10mM citric acid buffer, pH 6.0) at 100°C for 15 minutes for antigen retrieval. After washing three 5-minute with PBS (0.1M Tris-HCl, pH 7.6), non-specific binding was blocked by immersing the sections in PBS containing 10% goat serum at room temperature for 30 minutes. Then the sections were incubated with the primary antibody against EGFR (rabbit anti-human monoclonal antibody, 1:250, Abcam, MA, USA) and EpCAM (mouse anti-human monoclonal antibody, 1:200, Abcam, MA, USA) overnight at 4°C. After rinsing with PBS three times for 5-minutes, sections were incubated with horseradish-peroxidase-labeled goat anti-mouse/rabbit IgG/HRP conjugated polymer (PV-6000, ZSGB-BIO) for 20 minutes at 37°C. 3,3-diaminobenzidine tetrahydrochloride with hydrogen peroxidase (DAB-H2O2 substrate) was used as a chromogen. Next, the sections were washed with distilled water and counterstained with hematoxylin, dehydrated with ascending grades of ethanol, cleared with xylene and mounted with resinous mounting medium. The procedure was repeated in the negative control slides, using phosphate buffered saline solution instead of the primary antibody.

2.3 Histology scoring

EpCAM and EGFR positive staining were observed in the membrane of epithelial ovarian cancer cells. All sections were evaluated using a double-blind method. For each tissue section, immunostaining results were scored quantitatively in 5 high-power fields (200×magnification) and 100 tumor cells were counted in each field. The staining intensity was classified according to the following criteria: 0 = no staining; 1 = weak staining, 2 = moderate staining, 3 = strong staining. The percentage of positive staining tumor cells was scored as follows: 0 for ≤ 5%, 1 for 6 -25%, 2 for 26-50%, 3 for 51-75% and 4 for ≥76%. Values of staining intensity score were multiplied by the values of positive cells score to define the expression level: a score of 0-2 was considered negative, 3-4 was weak positive, 6-8 was moderate positive and 9-12 was strong positive.

2.4 Statistical methods

The Statistical Package for Social Sciences version 17.0 was used for all statistical analyses (SPSS 17.0, IBM, Chicago, IL, USA). Association between protein expression level of EpCAM or EGFR and clinicopathologic characteristics was identified using the Chi-square test or Fisher’s exact test. The Spearman correlation analysis was used to evaluate the correlations between EpCAM expression and EGFR expression. In all analyses, a P value <0.05 was considered as statistically significant.

3 Results

3.1 Clinical pathology information

The clinical and pathological parameters of patients were collected by retrospective review of the patients’ files and are described in Table 1. The diagnosis of histological type and histological grade were assigned according to the Classification of Ovarian Cancer (WHO 2004), among which 22 cases were serous cystadenocarcinoma, 5 mucinous cystadenocarcinoma, and 3 endometrioid carcinoma. Regarding tumor histological grading (tumor differentiated), 6 samples were well differentiated (Grade 1), 6 samples were moderately differentiated (Grade 2) and 18 samples were poorly differentiated (Grade 3). The epithelial ovarian carcinoma staged following the standards of International Federation of Gynecology and Obstetrics (FIGO, 2006), 8 patients had stage I, 2 patients had stage II, 13 patients had stage III, 7 patients had stage IV. 19 of the 30 patients had lymph node metastasis. The ages of patients ranged from 44 to 78 years (median 55.2 years).

Table 1

Correlation of EpCAM and EGFR expression with clinical pathological parameters in epithelial ovarian carcinoma

ParametersnEpCAM Positive (%)PEGFR Positive (%)P
Age
≥551410(71.4)0.3788(57.1)0.442
<551614(87.5)12(75.0)
Histological type
Serous2219(86.4)0.34316(72.7)0.375
Mucinous53(60.0)2(40.0)
Endometrioid32(66.7)2(66.7)
Differentiation
Well - moderately127(58.3)0.0264(33.3)0.004
Poorly1817(94.4)16(88.9)
FIGO stage
I - II105(50.0)0.0093(30.0)0.005
III - IV2019(95.0)17(85.0)
Lymphatic metastasis
No116(54.5)0.0164(36.4)0.015
Yes1918(94.7)16(84.2)

Notes: P<0.05 statistically significant

3.2 Expression of EpCAM and its correlation with clinicopathological parameter

EpCAM immunostaining pattern was diffuse throughout the tumor cell membrane. The proportion of immunoreactive cells among epithelial ovarian carcinoma specimens was 80% (Figure 1). In contrast, EpCAM expression in normal ovarian epithelial tissue was weak in 4 of 15 samples (26.7%, Figure 1). These result suggest that the level of EpCAM expression is increased in epithelial ovarian carcinoma compared to levels found in normal ovaries (X2=12.101, P<0.05, Table 2).

Figure 1 Representative immunohistochemical results of EpCAM in human normal ovary and epithelial ovarian carcinoma tissue sections. (A) Mild staining of EpCMA in normal ovary tissue. (B) Epithelia ovarian carcinoma tissue with weak positive (+) of EpCAM. (C) Epithelia ovarian carcinoma tissue with moderate positive (++) of EpCAM. (D) Epithelia ovarian carcinoma tissue with strong positive (+++) of EpCAM
Figure 1

Representative immunohistochemical results of EpCAM in human normal ovary and epithelial ovarian carcinoma tissue sections. (A) Mild staining of EpCMA in normal ovary tissue. (B) Epithelia ovarian carcinoma tissue with weak positive (+) of EpCAM. (C) Epithelia ovarian carcinoma tissue with moderate positive (++) of EpCAM. (D) Epithelia ovarian carcinoma tissue with strong positive (+++) of EpCAM

Table 2

Chi-square test analyses of EpCAM expression in EOCs and normal ovaries

EpCAM expression
n-++++++Positive rate (%)X2P
EOC3061012128012.1010.001
Normal151122026.7

As shown in Table 1, a statistically significant association was observed between EpCAM expression and FIGO stage and the degree of differentiation (histological grade), lymph node metastasis (P<0.05). No statistically significant correlation was found between EpCAM expression and age or histological type (P>0.05). The highest EpCAM expression was found in patients with lymph node metastasis. The level of EpCAM protein expression was found to be significantly elevated in patients with FIGO advanced stages (III-IV) versus FIGO early stages (I-II). The expression level of EpCAM ranged from moderately differentiated and well-differentiated (G1-G2) to poorly differentiated (G3).

3.3 Expression of EGFR and its correlation with clinicopathological parameter

The expression of EGFR was seen in the cell membrane of epithelial ovarian carcinoma (Figure 2). However EGFR immunostaining was negative in most normal ovarian epithelial tissue (Figure 2). Among 30 epithelial ovarian carcinoma patients, 24 patients were positive for EGFR staining (66.7%). In contrast, EGFR immunostaining was weakly positive in normal ovary (20%). Expression of EGFR was significantly greater in ovarian carcinoma samples than in the non-cancerous controls (X2=8.715, P<0.05, Table 3).

Figure 2 Representative immunohistochemical results of EGFR in human normal ovary and epithelial ovarian carcinoma tissue sections. (A) Mild staining of EGFR in normal ovary tissue. (B) Epithelia ovarian carcinoma tissue with weak positive (+) of EGFR. (C) Epithelia ovarian carcinoma tissue with moderate positive (++) of EGFR. (D) Epithelia ovarian carcinoma tissue with strong positive (+++) of EGFR
Figure 2

Representative immunohistochemical results of EGFR in human normal ovary and epithelial ovarian carcinoma tissue sections. (A) Mild staining of EGFR in normal ovary tissue. (B) Epithelia ovarian carcinoma tissue with weak positive (+) of EGFR. (C) Epithelia ovarian carcinoma tissue with moderate positive (++) of EGFR. (D) Epithelia ovarian carcinoma tissue with strong positive (+++) of EGFR

Table 3

Chi-square test analyses of EGFR expression in EOCs and normal ovaries

EGFR expressionX2P
n-++++++Positive rate (%)
EOC301077666.78.7150.003
Normal151221020

Correlations between the incidence of immunoreactivity for EGFR and the clinicopathological parameter of epithelial ovarian carcinoma are summarized in Table 1. The data show that a positive EGFR status is positively correlated with FIGO stages, the degree of differentiation (histological grade), and lymph node metastasis (P<0.05). The correlation between EpCAM expression and age orhistological type is non-significant (P>0.05). The percentage of EGFR positive tumor cells increase with increasing FIGO stages. Positive EpCAM expression rates were higher in poorly differentiated samples (G3) than those which were moderately differentiated and well-differentiated (G1-G2). The increased expression of EpCAM protein was more prevalent in lymph node metastasis of epithelial ovarian carcinoma compared to non-metastatic samples.

3.4 EpCAM and EGFR expression association in epithelial ovarian carcinoma

Spearsman was used to investigate the potential association between EpCAM and EGFR expression in epithelial ovarian carcinoma. 30 epithelial ovarian carcinoma specimens were used in this study. Among these, 19 epithelial ovarian carcinoma specimens exhibited positive immunostaining for both EpCAM and EGFR, 5 specimens exhibited negative for both EpCAM and EGFR, 5 specimens were only positive for EpCAM, and only 1 specimen was positive for EGFR. We found a significant positive correlation between EpCAM and EGFR expression in epithelial ovarian carcinoma tissues (Table 4, r=0.530, P=0.003).

Table 4

Correlation between EpCAM and EGFR expression in EOC

EGFR expressionEpCAM expressionTotalrP
PositiveNegative
Positive191200.5300.003
Negative5510
Total24630

4 Discussion

Acting as a mitogenic signal transducer, EpCAM, enhances cell proliferation with a direct influence on the cell cycle control, upregulates the proto-oncogene c-myc and the cell cycle regulating genes cyclin A and E, and induces signal transduction into the cell nucleus via the Wnt signaling pathway, which finally lead to tumorigenesis and development [4]. Previous studies have confirmed that EpCAM promotes invasion and metastasis of tumor cells, and EpCAM positive cells have a stronger capacity of cell proliferation compared with EpCAM negative cells [11]. The percentage of positive EpCAM expression in metastatic gastric carcinoma has also been found to be higher than that of nonmetastatic gastric carcinoma [12]. The intensity of EpCAM expression is associated with tumor differentiation, stage of disease, and metastasis [13-15]. Our study revealed that epithelial ovarian carcinoma tissues exhibit higher expression of EpCAM when compared with normal ovarian tissues, and demonstrated that upregulation of EpCAM was associated with FIGO stage and the degree of differentiation, lymph node metastasis.

EGFR, as a transmembrane tyrosine kinase receptor, specifically binds to epidermal growth factor (EGF) or transforming growth factor-α (TGF-α), causing tyrosine kinase auto-phosphorylation, which in turn activates the phosphatidylinositol 3-kinase pathway (PI3K/Akt pathway) and ras-raf-mitogen-activated protein kinase pathway (Ras/Raf/MAPK pathway) [16]. In physiological processes, EGFR regulates cell differentiation and the cell cycle, and also promotes repair of wound tissue. In pathological processes, overexpression of EGFR has been observed in a variety of human cancers, such as breast, gastric, and cervical cancers [17-19]. The overexpression of EGFR continuously transmits signals to cells, which interfere with the normal regulation of cell differentiation and cycle, which in turn contribute to cells’ continued proliferation and malignant transformation [20]. One study reported that the percentage of EGFR expression in ovarian serous carcinomas was 64%, and the strong positive EGFR expression was detected in high grade tumors [21]. The present study revealed that there was more frequent expression of EGFR in epithelial ovarian cancer than normal ovary, and also found a positive correlation between EGFR expression and FIGO stage, tumor differentiation, and lymph node metastasis. Our results further suggest that the overexpression of EGFR enhances the metastasis and invasion of tumor cells.

Multiple genes co-regulate the proliferation of ovarian cancer cells. Our study revealed that EpCAM and EGFR are associated with the malignant potential of EOC, and detected a positive correlation between EpCAM and EGFR protein expression in EOC. These results further suggest that the co-expression of EpCAM and EGFR may serve as a potential biomarker for evaluating the progression of epithelial ovarian cancer and may provide a promising molecular therapeutic target for advanced stage epithelial ovarian cancer. However larger scale investigations with more specimens at different histological types and stages are required.

  1. Conflict of interest: No authors report any conflict of interest.

References

[1] Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A., Global cancer statistics, 2012, CA Cancer J Clin, 2015, 65, 87-10810.3322/caac.21262Suche in Google Scholar PubMed

[2] Siegel R.L., Miller K.D., Jemal A., Cancer statistics, 2015, CA Cancer J Clin, 2015, 65, 5-2910.3322/caac.21254Suche in Google Scholar PubMed

[3] van der Gun B.T., Melchers L.J., Ruiters M.H., de Leij L.F., McLaughlin P.M., Rots M.G., EpCAM in carcinogenesis: the good, the bad or the ugly, Carcinogenesis, 2010, 31, 1913-192110.1093/carcin/bgq187Suche in Google Scholar PubMed

[4] Imrich S., Hachmeister M., Gires O., EpCAM and its potential role in tumor-initiating cells, Cell Adh Migr, 2012, 6, 30-3810.4161/cam.18953Suche in Google Scholar PubMed PubMed Central

[5] Spizzo G., Fong D., Wurm M., Ensinger C., Obrist P., Hofer C., et al., EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis, J Clin Pathol, 2011, 64, 415-42010.1136/jcp.2011.090274Suche in Google Scholar PubMed PubMed Central

[6] Maetzel D., Denzel S., Mack B., Canis M., Went P., Benk M., et al., Nuclear signalling by tumour-associated antigen EpCAM, Nat Cell Biol, 2009, 11, 162-17110.1038/ncb1824Suche in Google Scholar PubMed

[7] Uberall I., Kolar Z., Trojanec R., Berkovcova J., Hajduch M., The status and role of ErbB receptors in human cancer, Exp Mol Pathol, 2008, 84, 79-8910.1016/j.yexmp.2007.12.002Suche in Google Scholar PubMed

[8] Hudson L.G., Zeineldin R., Silberberg M., Stack M.S., Activated epidermal growth factor receptor in ovarian cancer, Cancer Treat Res, 2009, 149, 203-22610.1007/978-0-387-98094-2_10Suche in Google Scholar PubMed PubMed Central

[9] Yarden Y., Pines G., The ERBB network: at last, cancer therapy meets systems biology, Nat Rev Cancer, 2012, 12, 553-56310.1038/nrc3309Suche in Google Scholar PubMed

[10] Sheng Q., Liu J., The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer, Br J Cancer, 2011, 104, 1241-124510.1038/bjc.2011.62Suche in Google Scholar PubMed PubMed Central

[11] Mitra M., Kandalam M., Harilal A., Verma R.S., Krishnan U.M., Swaminathan S., et al., EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy, Mol Vis, 2012, 18, 290-308Suche in Google Scholar

[12] Du W., Ji H., Cao S., Wang L., Bai F., Liu J., et al., EpCAM: a potential antimetastatic target for gastric cancer, Dig Dis Sci, 2010, 55, 2165-217110.1007/s10620-009-1033-8Suche in Google Scholar PubMed

[13] Bae J.S., Noh S.J., Jang K.Y., Park H.S., Chung M.J., Park C.K., et al., Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma, Int J Oncol, 2012, 41, 2150-215810.3892/ijo.2012.1631Suche in Google Scholar PubMed

[14] Chan A.W., Tong J.H., Chan S.L., Lai P.B., To K.F., Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma, Histopathology, 2014, 64, 935-95010.1111/his.12342Suche in Google Scholar PubMed

[15] Ni J., Cozzi P.J., Duan W., Shigdar S., Graham P.H., John K.H., et al., Role of the EpCAM (CD326) in prostate cancer metastasis and progression, Cancer Metastasis Rev, 2012, 31, 779-79110.1007/s10555-012-9389-1Suche in Google Scholar PubMed

[16] Lemmon M.A., Schlessinger J., Cell signaling by receptor tyrosine kinases, Cell, 2010, 141, 1117-113410.1016/j.cell.2010.06.011Suche in Google Scholar PubMed PubMed Central

[17] Fukazawa E.M., Baiocchi G., Soares F.A., Kumagai L.Y., Faloppa C.C., Badiglian-Filho L., et al., Cox-2, EGFR, and ERBB-2 expression in cervical intraepithelial neoplasia and cervical cancer using an automated imaging system, Int J Gynecol Pathol, 2014, 33, 225-23410.1097/PGP.0b013e318290405aSuche in Google Scholar PubMed

[18] Kim M.A., Lee H.S., Lee H.E., Jeon Y.K., Yang H.K., Kim W.H., EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number, Histopathology, 2008, 52, 738-74610.1111/j.1365-2559.2008.03021.xSuche in Google Scholar PubMed

[19] Liu D., He J., Yuan Z., Wang S., Peng R., Shi Y., et al., EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray, Med Oncol, 2012, 29, 401-40510.1007/s12032-011-9827-xSuche in Google Scholar PubMed

[20] Siwak D.R., Carey M., Hennessy B.T., Nguyen C.T., McGahren Murray M.J., Nolden L., et al., Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges, J Oncol, 2010, 2010, 56893810.1155/2010/568938Suche in Google Scholar PubMed PubMed Central

[21] Brustmann H., Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome, Int J Gynecol Pathol, 2008, 27, 380-38910.1097/PGP.0b013e31815d060dSuche in Google Scholar PubMed

Received: 2016-10-1
Accepted: 2017-1-27
Published Online: 2017-3-16

© 2017 Jingying Zheng et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
https://doi.org/10.1515/med-2017-0007
Schlagwörter für diesen Artikel
Epithelial ovarian cancer; EpCAM; EGFR; Immunohistochemistry
Creative Commons
BY-NC-ND 3.0

Artikel in diesem Heft

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2026 De Gruyter Brill
Heruntergeladen am 25.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0007/html
Button zum nach oben scrollen